Muehlenkreiskliniken AöR

Az itteni vizsgálatok

Miről szól a helyszín 34 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Tüdőrák8 vizsgálat
• Gyermekkori daganatok6 vizsgálat
• Akut mieloid leukémia (AML)4 vizsgálat
• Mieloproliferatív neopláziák4 vizsgálat
• Akut limfoid leukémia (ALL)3 vizsgálat
• Hidradenitis suppurativa3 vizsgálat
• Melanóma3 vizsgálat
• Stroke (szélütés)3 vizsgálat
• Follikuláris limfóma2 vizsgálat
• Diffúz nagy B-sejtes limfóma (DLBCL)1 vizsgálat
• Köpenysejtes limfóma1 vizsgálat
• Mielóma multiplex1 vizsgálat
• és még 2

Fázis

• 3. fázis29 vizsgálat
• 2. fázis4 vizsgálat
• 2/3. fázis1 vizsgálat

Állapot

• Toboroz18 vizsgálat
• Még nem toboroz6 vizsgálat
• Fut, nem toboroz5 vizsgálat
• Lezárult5 vizsgálat

Fő szponzor

• AstraZeneca4 vizsgálat
• Novartis Pharmaceuticals3 vizsgálat
• Stichting Hemato-Oncologie voor Volwassenen Nederland2 vizsgálat
• AbbVie1 vizsgálat
• Celgene1 vizsgálat
• és még 23

Futó vizsgálatok

• Toboroz

  A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  NCT07623161· 3. fázis· Takeda· Forrás

• Még nem toboroz

  AIEOP-BFM ALL 2025 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia

  2025-522190-11-01· 3. fázis· Universitaetsklinikum Schleswig-Holstein AöR· Forrás

• Toboroz

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  NCT07626411· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

  NCT07665437· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  NCT07365241· 3. fázis· AbbVie· Forrás

• Toboroz

  A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

  NCT07357727· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Thrombolysis with Tenecteplase for Acute Ischemic Stroke in Patients taking Direct Oral Anticoagulants

  2025-521762-99-00· 3. fázis· University Medical Center Hamburg-Eppendorf· Forrás

• Toboroz

  Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

  NCT07223814· 3. fázis· Stichting Hemato-Oncologie voor Volwassenen Nederland· Forrás

• Toboroz

  A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

  NCT07384975· 2. fázis· Navigator Medicines, Inc.· Forrás

• Toboroz

  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  NCT07211958· 3. fázis· Syndax Pharmaceuticals· Forrás

• Toboroz

  Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

  NCT07197307· 2. fázis· Universität Münster· Forrás

• Toboroz

  Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

  NCT07291037· 3. fázis· AstraZeneca· Forrás

• Toboroz

  A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia (AML) with a specific gene abnormality who have not previously been treated and who are not eligible for intensive chemotherapy.

  2024-512753-24-00· 3. fázis· Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting· Forrás

• Toboroz

  Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

  NCT05691244· 3. fázis· Pharmazz, Inc.· Forrás

• Toboroz

  Study of Sacituzumab Govitecan Versus Standard of Care in Participants with Previously Treated Extensive Stage Small Cell Lung Cancer

  2024-515884-69-00· 3. fázis· Gilead Sciences Inc.· Forrás

• Toboroz

  Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

  NCT06697301· 2/3. fázis· Eikon Therapeutics· Forrás

• Toboroz

  Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

  NCT06652438· 3. fázis· Stichting Hemato-Oncologie voor Volwassenen Nederland· Forrás

• Toboroz

  Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC

  NCT06810609· 2. fázis· University Hospital, Bonn· Forrás

• Fut, nem toboroz

  A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa

  NCT06840392· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

  NCT06627647· 3. fázis· AstraZeneca· Forrás

• Toboroz

  A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

  NCT06692738· 3. fázis· AstraZeneca· Forrás

• Toboroz

  A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

  NCT06549595· 3. fázis· AstraZeneca· Forrás

• Toboroz

  A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

  NCT06203210· 3. fázis· Daiichi Sankyo· Forrás

• Toboroz

  Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)

  NCT05008809· 3. fázis· Dominik Paul Modest· Forrás

• Toboroz

  International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma

  NCT04043494· 3. fázis· University Hospital Muenster· Forrás

• Fut, nem toboroz

  Trial on the Effect of Isatuximab to Lenalidomide/Bortezomib/Dexamethasone (RVd) Induction and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma (GMMG HD7)

  NCT03617731· 3. fázis· University of Heidelberg Medical Center· Forrás

• Toboroz

  Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017

  NCT03643276· 3. fázis· Martin Schrappe· Forrás

• Fut, nem toboroz

  Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

  NCT03007147· 3. fázis· Children's Oncology Group· Forrás

• Fut, nem toboroz

  The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia

  NCT02577926· 2. fázis· RWTH Aachen University· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák7 toboroz
• Akut mieloid leukémia (AML)4 toboroz
• Gyermekkori daganatok4 toboroz
• Stroke (szélütés)3 toboroz
• Follikuláris limfóma2 toboroz
• Hidradenitis suppurativa2 toboroz
• Mieloproliferatív neopláziák2 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Melanóma1 toboroz
• Pitvarfibrilláció1 toboroz
• Vastagbélrák1 toboroz

Lezárt vizsgálatok

• Fut, nem toboroz

  A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

  NCT06346067· 3. fázis· Erasca, Inc.· Forrás

• Fut, nem toboroz

  Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

  NCT05502237· 3. fázis· Gilead Sciences· Forrás

• Fut, nem toboroz

  IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

  NCT05155254· 3. fázis· IO Biotech· Forrás

• Lezárult

  An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib

  NCT03952039· 3. fázis· Celgene· Forrás

• Lezárult

  autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized European MCL Network trial

  2024-511235-10-00· 3. fázis· Klinikum der Universitaet Muenchen AöR· Forrás